Immunai: Mikael Dolsten

Immunai has named Mikael Dolsten to its board of directors. Dolsten was previously Pfizer's chief scientific officer and president of research and development. Prior to that, he held senior leadership roles at Wyeth, Boehringer Ingelheim, and AstraZeneca.